Could This Alzheimer’s Disease Drug Really Be Worth $20 Billion? -- The Motley Fool : fool

as declared in fool

Could This Alzheimer's Disease Drug Really Be Worth $20 Billion? -- The Motley Fool

Could This Alzheimer's Disease Drug Really Be Worth $20 Billion? -- The Motley Fool

Biogen's (NASDAQ:BIIB) plaque-busting Alzheimer's disease (AD) drug candidate, aducanumab, could represent a jaw-dropping $20 billion peak commercial opportunity for the company and its shareholders.Putting this monstrous figure into context, this experimental medicine has the potential to even surpass AbbVie's anti-inflammatory drug, Humira, which is on track to generate upwards of $16 billion in global sales by 2018 and is currently the world's best-selling drug.Although this $20 billion peak sales figure may sound ridiculous at first, there are some solid reasons to believe that it's not completely far-fetched.First off, there are presently no disease-modifying treatments available for this devastating neurodegenerative disorder, reflecting the astronomically high failure rate of experimental AD drugs.


furthermore wpri

Families, doctors look to fight Alzheimer's Disease

Families, doctors look to fight Alzheimer's Disease

Related Coverage Walk to End Alzheimer's: Two chances to join the fight in RIPROVIDENCE, R.I. (WPRI) — More than five million Americans, including 23,000 in Rhode Island alone, live with Alzheimer's Disease.Tonight on Eyewitness News starting at 5, we'll talk to a Rhode Island family who lost a loved one to early on-set Alzheimer's, and a local doctor working on ground-breaking research for the disease which currently has no cure.RELATED: Walk to End Alzheimer'sAlzheimer's Disease is the most common form of dementia.Every 66 seconds, someone in the United States develops Alzheimer's.


coupled with fox13now

Utahns walking together to end Alzheimer's Disease

Utahns walking together to end Alzheimer's Disease

Please enable Javascript to watch this videoSALT LAKE CITY, Utah - Hundreds of Utahns are raising awareness and funds to help fight Alzheimer's disease.The Alzheimer's Association Walk was held on the Utah State Capitol's South Lawn on Saturday.Last year this event raised over $250,000 which contributed to more than $77,000,000 raised nationwide for care, support and research efforts given to those impacted by the disease.Caregivers say a lot of the time, people don't know how crippling it can be.